Form 4: Director John B. Henneman III Increases Stake in Orthofix

Orthofix Medical Inc. Director John B. Henneman III purchased 5,000 shares of common stock at $12.259 per share.

Summary

• Director John B. Henneman III acquired 5,000 shares of Orthofix Medical Inc. (OFIX) common stock.
• The transaction occurred on May 7, 2026, at a price of $12.259 per share.
• Following this purchase, the director's total beneficial ownership increased to 90,809 shares.
• The total includes 48,347 deferred stock units and 2,103 shares acquired through the company's Stock Purchase Plan.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as director-level insider buying often indicates confidence in the company's long-term strategic direction.

Positives

• Insider confidence is demonstrated by the director's open-market purchase of company stock.
• The purchase increases the alignment of interests between the director and shareholders.

Negatives

• None identified in this filing.

Risks

• None identified in this filing.

Future Outlook

Not applicable.

Industry Context

StockSavvy.ai notes that insider buying is generally viewed as a positive signal by the market, suggesting that leadership believes the current share price is undervalued or that future prospects are favorable.

Comparison to Industry Standards

• Insider purchases by board members are standard corporate governance activities and align with typical market behavior for publicly traded medical device companies.

Stakeholder Impact

• Shareholders may interpret this purchase as a sign of internal confidence in the company's valuation.

Next Steps

• None specified.

Key Dates

Keywords

OFIX, Orthofix Medical, Insider Trading, Form 4, Director Purchase